The impact of missing data and how it is handled on the rate of false‐positive results in drug development
Year: 2007
Type: article
Source: Pharmaceutical Statistics
DOI: 10.1002/pst.310
Institutions: KCI (United States), Eli Lilly (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2119304424
